Travere Therapeutics (TVTX) Goodwill & Intangibles (2013 - 2026)

Travere Therapeutics (TVTX) has 14 years of Goodwill & Intangibles data on file, last reported at $110.0 million in Q1 2026.

• For the quarter ending Q1 2026, Goodwill & Intangibles rose 5.18% year-over-year to $110.0 million; the trailing twelve-month figure through Mar 2026 stood at $110.0 million (up 5.18% YoY), and the FY2025 full-year result was $113.9 million, up 8.68% from the prior year.
• Goodwill & Intangibles for Q1 2026 stood at $110.0 million, down from $113.9 million in the prior quarter.
• Across five years, Goodwill & Intangibles topped out at $163.8 million in Q1 2023 and bottomed at $97.9 million in Q4 2022.
• The 5-year median for Goodwill & Intangibles is $107.7 million (2023), against an average of $120.5 million.
• The widest annual swing landed in 2024, when Goodwill & Intangibles plunged 37.73%; it then advanced 8.68% in 2025.
• A 5-year view of Goodwill & Intangibles shows it stood at $97.9 million in 2022, then climbed by 7.53% to $105.2 million in 2023, then decreased by 0.45% to $104.8 million in 2024, then gained by 8.68% to $113.9 million in 2025, then fell by 3.36% to $110.0 million in 2026.
• The last three Goodwill & Intangibles figures came in at $110.0 million (Q1 2026), $113.9 million (Q4 2025), and $110.2 million (Q3 2025), per Business Quant data.

Peer Comparison